Nutreco, Aqua-Spark lead $25 million investment in aquaculture biotech company

The company will use the funds to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics.

Jaroslaw Dastych, CEO of Proteon Pharmaceuticals. The group has the backing of seafood investment fund Aqua-Spark and feed giant Nutreco.
Jaroslaw Dastych, CEO of Proteon Pharmaceuticals. The group has the backing of seafood investment fund Aqua-Spark and feed giant Nutreco.Foto: Jaroslaw Dastych/Researchgate
Published 10 August 2021, 12:48Updated 10 August 2021, 16:16
NutrecoSkrettingAqua-SparkMergers & AcquisitionsPrivate equity